By helping reduce appetite, increase feelings of fullness, and support metabolic efficiency, tirzepatide may promote meaningful and sustainable weight loss when used alongside healthy lifestyle changes under licensed provider supervision
A landmark trial of more than 17,600 overweight and obese patients with cardiovascular disease (but not diabetes), found that semaglutide reduced their risk of serious cardiovascular events by 20%
By stimulating the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, Tirzepatide helps achieve more balanced levels of insulin and glucose in the body
B 12 deficiency can also result in neurological problems
Langford AA, Gelderblom H, Kunze RO, Pohle HD, Reichart PA
The key during the first 2 weeks at 12mg is managing the GI adjustment